# Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma

> **NCT05587543** · EARLY_PHASE1 · RECRUITING · sponsor: **Fudan University** · enrollment: 24 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **BEHAVIORAL:** PK Blood Collection
- **DRUG:** CAR
- **DRUG:** TCR

## Key facts

- **NCT ID:** NCT05587543
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-28
- **Primary completion:** 2027-10
- **Final completion:** 2030-10
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05587543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05587543, "Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05587543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*